Hodgkin lymphoma with leptomeningeal involvement

Letters and correspondence submitted for possible publication must be identified as such. Text length must not exceed 500 words and five bibliographic references. A single concise figure or table may be included if it is essential to support the communication. Letters not typed double-spaced will not be considered for publication. Letters not meeting these specifications will not be returned to authors. Letters to the Editor are utilized to communicate a single novel observation or finding. Correspondence is to be used to supplement or constructively comment on the contents of a publication in the journal and cannot exceed the restrictions for Letters to the Editor. The Editor reserves the right to shorten text, delete objectional comments, and make other changes to comply with the style of the journal. Permission for publication must be appended as a postscript. Submissions must be sent to Jay Umbreit, MD, PhD, Editor of Brief Reports/Letters to Editors, American Journal of Hematology, Winship Cancer Institute, Emory University, 1365-B Clifton Road, Suite B4100, Atlanta, GA 30322 to permit rapid consideration for publication.

[1]  D. Wilke,et al.  Intracranial Presentation of Systemic Hodgkin's Disease , 2004, Leukemia & lymphoma.

[2]  J. Licht,et al.  The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRT. , 2004, Blood.

[3]  J. Lynch,et al.  Paraneoplastic manifestations of lymphoma. , 2004, Clinical lymphoma.

[4]  R. Pandita,et al.  Pregnancy in chronic myeloid leukemia patients treated with alpha interferon , 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[5]  Neeraj Kumar,et al.  Myeloneuropathy and anemia due to copper malabsorption , 2004, Journal of Neurology.

[6]  A. Scuto,et al.  Cotreatment with 17-Allylamino-Demethoxygeldanamycin and FLT-3 Kinase Inhibitor PKC412 Is Highly Effective against Human Acute Myelogenous Leukemia Cells with Mutant FLT-3 , 2004, Cancer Research.

[7]  P. Terrosu,et al.  Asymptomatic cardiac lymphoma in a hepatitis C virus-positive thalassemic patient. , 2004, Italian heart journal : official journal of the Italian Federation of Cardiology.

[8]  V. Ozkocaman,et al.  Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with leukapheresis during pregnancy: a case report and review of the literature. , 2004, Japanese journal of clinical oncology.

[9]  Gerald Hoefler,et al.  Common alterations in gene expression and increased proliferation in recurrent acute myeloid leukemia , 2004, Oncogene.

[10]  L. Dubertret,et al.  Paraneoplastic acral vascular syndrome: epidemiologic features, clinical manifestations, and disease sequelae. , 2002, Journal of the American Academy of Dermatology.

[11]  K. Takenaka,et al.  Bilateral adrenal hemorrhage in essential thrombocythemia , 2002, Annals of Hematology.

[12]  B. Barlogie,et al.  Hypothyroidism in patients with multiple myeloma following treatment with thalidomide. , 2002, The American journal of medicine.

[13]  A. Mubarak,et al.  Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon‐α in 1st trimester: Report of 3 cases and review of the literature , 2002, American journal of hematology.

[14]  E. Estey,et al.  Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia. , 2001, The Journal of clinical investigation.

[15]  G. Lefort,et al.  Diabetes insipidus revealing acute myelogenous leukaemia with a high platelet count, monosomy 7 and abnormalities of chromosome 3: a new entity? , 2001, European journal of haematology.

[16]  K. Moise Non-anti-D antibodies in red-cell alloimmunization. , 2000, European journal of obstetrics, gynecology, and reproductive biology.

[17]  A. Imai,et al.  Brain involvement in Hodgkin's disease: case reports and review of the literature. , 2000, Radiation medicine.

[18]  A. Ganesh,et al.  Traumatic hyphaema and sickle cell retinopathy in a patient with sickle cell-haemoglobin E (HbSE) disease , 2000, Eye.

[19]  R. Liang,et al.  Meningeal relapse in Hodgkin's disease. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Butera,et al.  Case 1. Hodgkins's disease presenting as a cystic neck mass. , 2000, Journal of Clinical Oncology.

[21]  B. Barlogie,et al.  Antitumor activity of thalidomide in refractory multiple myeloma. , 1999, The New England journal of medicine.

[22]  C. Jansen,et al.  Sickle cell‐like crisis and bone marrow necrosis associated with parvovirus B19 infection and heterozygosity for haemoglobins S and E , 1999, Journal of internal medicine.

[23]  P. Haslett,et al.  Thalidomide Costimulates Primary Human T Lymphocytes, Preferentially Inducing Proliferation, Cytokine Production, and Cytotoxic Responses in the CD8+ Subset , 1998, The Journal of experimental medicine.

[24]  S. Halpern,et al.  Hodgkin's disease presenting with digital ischaemia , 1994, Clinical and experimental dermatology.

[25]  A. Reunanen,et al.  Body iron stores and risk of cancer , 1994, International journal of cancer.

[26]  P. Smith,et al.  A case of Burkitt's lymphoma presenting with digital ischaemia , 1993, Acta paediatrica.

[27]  Scott T. Miller,et al.  Sickle cell-hemoglobin E disease: clinical findings and implications. , 1991, The Journal of pediatrics.

[28]  J. Garioch,et al.  T‐Cell lymphoma presenting with severe digital ischaemia , 1991, Clinical and experimental dermatology.

[29]  R. Cuthbert,et al.  Central nervous system involvement in haematological malignancies. , 1989, Clinical and laboratory haematology.

[30]  A. Chapelle,et al.  Monosomy 7 predisposes to diabetes insipidus in leukaemia and myelodysplastic syndrome , 1987, European journal of haematology.

[31]  B. O'neill,et al.  Systemic cancer presenting as diabetes insipidus. Clinical and radiographic features of 11 patients with a review of metastatic‐induced diabetes insipidus , 1983, Cancer.

[32]  M. Sapozink,et al.  Intracranial Hodgkin's disease. A report of 12 cases and review of the literature , 1983, Cancer.

[33]  Trudy Williams,et al.  Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery , 2007, Journal of Gastrointestinal Surgery.

[34]  W. Watson,et al.  Acute Wernicke's Encephalopathy following Bariatric Surgery: Clinical Course and MRI Correlation , 2004, Obesity surgery.

[35]  M. Kehinde,et al.  Ocular findings in sickle cell disease patients in Lagos. , 2004, The Nigerian postgraduate medical journal.

[36]  H. Kantarjian,et al.  SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes. , 2003, Blood.

[37]  A. Taher,et al.  Beta-thalassemia intermedia and non-Hodgkin's lymphoma. , 2002, Hemoglobin.

[38]  C. Mecucci,et al.  3q aberration and monosomy 7 in ANLL presenting with high platelet count and diabetes insipidus. , 1994, Haematologica.

[39]  G. Schilirò,et al.  Thalassemia major and malignancies. , 1987, American journal of hematology.

[40]  A. Marini,et al.  Severe pancytopenia due to copper deficiency. Case report. , 1986, Acta haematologica.

[41]  S. Refetoff,et al.  Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases. , 1976, Clinical endocrinology.